You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窩輪》【瑞通認股證牛熊證】觀察美團能否收復20天線 資金即市開牛證 港交所曾彈4% 美團牛52518 熊66061/港交牛57042 熊68214/阿里價外中短期購20605 短期購13864
阿思達克 07-28 10:37
投資者憧憬美國政府將落實新一輪經濟刺激方案,道指隔晚收報26584點,升114點(或0.4%)。恆指昨失守50天線,收報24603點,跌102點(或0.4%),全日徘徊在24500至25000之間。今早一度回升逾300點,重上24900點,但始終受制於25000點。恆指好倉(牛證及認購權證)昨淨流入逾1500萬港元(下同),恆指淡倉(熊證及認沽權證)同日淨流出逾480萬元,反映投資者略為看好港股回升。昨日恆指牛證街貨重貨區為收回價24100至24199點,而熊證街貨重貨區為收回價26000至26099點。

美團點評(03690)昨先升後回,曾挫4.5%,下試182元,最終收跌近3%於185元。有傳美團加碼投資即將在美國上市的理想汽車。美團今早回升逾2%,於190元水平爭持。技術上,昨日美團跌穿10天(192.7元)及20天線(193.3元),短線觀察美團能否收復20天線,因上次明顯失守20天線已是3月下旬其股價跌至70元邊的時候。昨分別有逾130萬元和30萬元淨流入其好倉和淡倉。

據報港交所(00388)調整內部架構,成立結構性產品開發小組。港交所昨險守20天線收市,報353.8元,跌1.8%。今早曾回升3.8%,高見367.4元,其後維持約2%的升幅,於360元關口徘徊。昨有逾640萬元淨流入其好倉,淡倉同日則有逾280萬元淨流出。

平保(02318)連跌四個交易日,累跌3.7%,昨收報83.15元。平保宣布與日本鹽野義製藥成立兩家合資公司。另早前有傳平保旗下陸金所擬赴美上市。平保今早靠穩,於84元附近爭持。昨有逾90萬元淨流入其好倉,淡倉同日則有逾50萬元淨流出。

阿里巴巴(09988)昨平收於239元,已是「ATMX」中表現最好。投資者憧憬阿里可在八月恆指季檢時晉身藍籌,以及受惠於螞蟻集團在香港和上海上市的計劃。阿里今早升逾2%,重上245元,收復10天線(242.9元),近期續於20天線(239元)見支持。昨分別有逾940萬元和360萬元淨流出其好倉和淡倉。

瑞通相關認股證之選擇:

港交輕微價外、中短期購15473,行使價:398.88元,2021年1月到期,實際槓桿:6.3倍

港交輕微價外、中年期沽16498,行使價:323.88元,2021年2月到期,實際槓桿:4.9倍

平保輕微價外、中短期購21868,行使價:88.88元,2020年12月到期,實際槓桿:10倍

平保輕微價外、短期沽23131,行使價:78.88元,2020年9月到期,實際槓桿:11倍

美團輕微價外、中短期購14356,行使價:201.08元,2020年12月到期,實際槓桿:5.7倍

美團輕微價外、中短期沽18332,行使價:162.78元,2020年12月到期,實際槓桿:4.1倍

阿里價外、中短期購20605,行使價:288.8元,2020年12月到期,實際槓桿:7.1倍

阿里輕微價外、短期購13864,行使價:258.8元,2020年10月到期,實際槓桿:9.1倍

阿里輕微價外、中短期沽20606,行使價:218.8元,2020年12月到期,實際槓桿:5.5倍

匯豐輕微價外、中短期購26020,行使價:40.8元,2020年11月到期,實際槓桿:9.9倍

匯豐輕微價外、中短期沽12662,行使價:32.9元,2020年12月到期,實際槓桿:5.9倍

瑞通相關牛熊證之選擇:

恆指牛證53781,收回價:24330點,槓桿比率:42.1倍

恆指熊證66292,收回價:25490點,槓桿比率:27.6倍

港交牛證57042,收回價:346.799元,槓桿比率:19.7倍

港交熊證68214,收回價:384.88元,槓桿比率:13.7倍

平保牛證54546,收回價:79.25元,槓桿比率:16.7倍

平保熊證53262,收回價:91.8元,槓桿比率:8.3倍

美團牛證52518,收回價:178.399元,槓桿比率:12.6倍

美團熊證66061,收回價:206.49元,槓桿比率:9.2倍

阿里牛證54479,收回價:231.5元,槓桿比率:15倍

阿里熊證68095,收回價:262.88元,槓桿比率:11.5倍

重要風險通知

本結構性產品並無抵押品。

結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。

閣下投資前應了解產品風險,如有需要應諮詢專業建議。~

重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account